Reacta Biotech’s £2.5 Million Investment Round

Irwin Mitchell advised Praetura Ventures on the matter.Reacta Biotech produces clinical diagnostics kits for food allergy testing. The business improves the efficiency, accuracy and safety of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here